Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02783742 · ClinicalTrials.gov registry record · NA

Provider-Patient Communication Coaching

A NA study of Communication and Provider Burnout, sponsored by Duke University.

Completed
Registry status
NA
Development phase
859
Enrollment target
1
Study location

NCT02783742: Completed NA study of Communication and Provider Burnout, sponsored by Duke University.

NCT02783742 is a NA study of Communication and Provider Burnout that has completed, run by Duke University. The registered enrollment target is 859 participants, below the 1,396-participant average among 34 other Communication trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02783742, a NA study of Communication and Provider Burnout, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
859 participants
Enrollment target
1
Study location

Study Summary

To examine the effect of a coaching intervention on provider burnout and communication

Interventions

  • BEHAVIORAL Communication coaching

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 859 participants
Start Date 2016-06-20
Est. Completion 2020-01-30
Phase NA
Duke University

1,725 total trials

What the finished NCT02783742 record still lists

NCT02783742 is an interventional study that assigns participants to a tested intervention. The registered 859 participants enrollment target is mid-sized for trials with a published cap, below the 1,396-participant average among 34 other Communication trials with a reported enrollment target (38% lower).

The record links to 2 conditions, with Communication appearing as the primary indexed condition, and to 1 intervention - of which Communication coaching is the first listed.

NCT02783742 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02783742 about?

NCT02783742 is a clinical study titled "Provider-Patient Communication Coaching". To examine the effect of a coaching intervention on provider burnout and communication

What is the current status of trial NCT02783742?

This trial is currently completed. It is a NA study. The enrollment target is 859 participants. The study started on 2016-06-20. Estimated completion is 2020-01-30.

What conditions does trial NCT02783742 study?

This clinical trial studies the following conditions: Communication, Provider Burnout.

What interventions are being tested in trial NCT02783742?

The interventions under investigation include: Communication coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT02783742?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02783742 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02783742's enrollment target sits among peer trials

859 8th of 34 higher than 27 of 34 other Communication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04541381 · 860 participants · NA

    The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

  • NCT05211895 · 860 participants · Phase 3

    A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

  • NCT06161025 · 860 participants · Phase 2

    A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • NCT06541574 · 860 participants · Phase 2

    Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02783742, the US trial registry maintained by the National Library of Medicine. NCT02783742 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.